Hansa Biopharma AB Hosts Virtual Event with Transplant Surgeons
Hansa Biopharma AB announced a virtual event featuring Professor Robert Montgomery and Professor Matthew Cooper to discuss the medical journey of highly sensitized patients awaiting a kidney transplant.
The event will share perspectives on the clinical relevance of the topline results from the US Phase 3 ConfIdeS study, focusing on imlifidase.
- Date: Wednesday, 12 November 2025
- Time: 9:00 AM EST / 15:00 PM CET
No direct quotes available in the provided text.
For more information, contact +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT.
Author's summary: Hansa Biopharma hosts a virtual event on kidney transplant insights.